Research reveals treatment non-adherence is partly to blame
A structured exercise program can reduce the apnoea-hypopnoea index by 30%, expert says.
Patients may be feeling unwell days ahead of the unexpected event, researchers say.
The study suggests ACE inhibitors and ARBs are safe, although a leading cardiologist suggests this is 'not the last word'.
But results of the VERTIS CV trial confirm that ertugliflozin cuts admissions for heart failure.
The largest trial to date on the topic resolves a controversy.
European and US approaches for deciding whether a patient can be treated at home give similar outcomes, study shows.
Intervention to inform patients about reducing stroke risk falls short of what's needed, researchers say.
The results could change clinical practice, leading cardiologist says.
Cardiovascular researcher Professor Martin Landray, from Oxford University, shares his thoughts.